Sharing this important information from LI-NET

 

Leslie Fried, JD

Senior Director, Center for Benefits Access

Office: 571.527.3992

xxxxxx@ncoa.org

 

National Council on Aging

Improving the lives of millions of older adults

251 18th Street South, Suite 500

Arlington, VA 22202

ncoa.org | @NCOAging

 

From: SHIP Directors [mailto:xxxxxx@LIST.NIH.GOV] On Behalf Of Simpson, Melissa (ACL)
Sent: Tuesday, January 02, 2018 12:13 PM
To: xxxxxx@LIST.NIH.GOV
Subject: LI NET - Opioid Limitation and MED (Morphine Equivalent Dose) edit

 

Please see the note below from Humana regarding opioids and the Part D LI NET program they administer.

 

 

 

LI NET will be included in the enterprise wide rollout of the opioid limitation (30 days) and MED (Morphine Equivalent Dosing) edits.  The go-live date for these are Jan 1, I apologize for the late notice.  As you probably know, this is an national effort to limit the opioid epidemic, dispensing abuses and is per CMS policy.  The 30 day limit should affect very few LI NET beneficiaries (a fraction of 1%) as most states already limit opioid day supply to 30 or less.

 

Attached are the communications being sent to the Pharmacies. 

 

 

 

LI NET Advocacy Line:  1-866-934-2019 (Exclusive for Advocacy groups)

 

cid:image003xxxxxx@01CEA4C3.98E251F0

LI NET Website: Contains up to date information related to Medicare’s Limited Income NET Program

www.Humana.com/LINET

 

LI NET Brochure: Overview of Medicare’s Limited Income – NET Program

http://apps.humana.com/marketing/documents.asp?file=1843634

 

Pharmacy 4 Steps Document: How to enroll a beneficiary and submit a claim for Pharmacists

http://apps.humana.com/marketing/documents.asp?file=2066961

 

LI NET Online Tutorials: with Free Continuing Education Credits

https://www.humana.com/pharmacy/pharmacists/linet-information

 

 

 


The information transmitted is intended only for the person or entity to which it is addressed
and may contain CONFIDENTIAL material. If you receive this material/information in error,
please contact the sender and delete or destroy the material/information.

Humana Inc. and its subsidiaries comply with applicable Federal civil rights laws and
do not discriminate on the basis of race, color, national origin, age, disability or
sex. Humana Inc. and its subsidiaries do not exclude people or treat them differently
because of race, color, national origin, age, disability or sex.

English: ATTENTION: If you do not speak English, language assistance services, free
of charge, are available to you. Call 1
8773201235 (TTY: 711).

Español (Spanish): ATENCIÓN: Si habla español, tiene a su disposición servicios
gratuitos de asistencia lingüística. Llame al 1
8773201235 (TTY: 711).

繁體中文(Chinese):注意:如果您使用繁體中文,您可以免費獲得語言援助
服務。請致電 18773201235 (TTY: 711)

Kreyòl Ayisyen (Haitian Creole): ATANSION: Si w pale Kreyòl Ayisyen, gen sèvis èd
pou lang ki disponib gratis pou ou. Rele 1
8773201235 (TTY: 711).

Polski (Polish): UWAGA: Jeżeli mówisz po polsku, możesz skorzystać z bezpłatnej
pomocy językowej. Zadzwoń pod numer 1
8773201235 (TTY: 711).

한국어 (Korean): 주의: 한국어를 사용하시는 경우, 언어 지원 서비스를 무료로
이용하실 있습니다. 18773201235 (TTY: 711)번으로 전화해 주십시오.

 


To unsubscribe from the SHIP-DIRECTORS list, click the following link:
http://list.nih.gov/cgi-bin/wa.exe?SUBED1=SHIP-DIRECTORS&A=1

The information contained in this electronic mail and its attachments is privileged and confidential. It is intended for the use of the addressee and others specifically authorized to receive it. If you are not the intended recipient, you are prohibited from disseminating, distributing or copying this communication. If you have received this e-mail in error, please delete it and notify us by replying to this e-mail immediately.